Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients

Alberto Borghetti; Gianmaria Baldin; Amedeo Capetti; Gaetana Sterrantino; Stefano Rusconi; Alessandra Latini; Andrea Giacometti; Giordano Madeddu; Chiara Picarelli; Ramona De Marco; Maria V. Cossu; Filippo Lagi; Roberto Cauda; Andrea De Luca; Simona Di Giambenedetto

doi:10.1097/QAD.0000000000001357

Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients

Alberto Borghetti^*
, Gianmaria Baldin
, Amedeo Capetti
, Gaetana Sterrantino
, Stefano Rusconi
, Alessandra Latini
, Andrea Giacometti
, Giordano Madeddu
, Chiara Picarelli
, Ramona De Marco
, Maria V. Cossu
, Filippo Lagi
, Roberto Cauda
, Andrea De Luca
, Simona Di Giambenedetto

^*Corresponding author

University of Milan
Azienda Ospedaliera Careggi
IRCCS Istituto Dermatologico Santa Maria e San Gallicano – Roma
Marche Polytechnic University
University of Sassari
Azienda Ospedaliera Universitaria Senese

Research output: Contribution to journal › Article

29 Citations (Scopus)

Abstract

Not Available

Original language	English
Pages (from-to)	457-459
Number of pages	3
Journal	AIDS
Volume	31
Issue number	3
DOIs	https://doi.org/10.1097/QAD.0000000000001357
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Immunology and Allergy
Immunology
Infectious Diseases

Keywords

Immunology
Immunology and Allergy
Infectious Diseases

Access to Document

10.1097/QAD.0000000000001357

Cite this

Borghetti, A., Baldin, G., Capetti, A., Sterrantino, G., Rusconi, S., Latini, A., Giacometti, A., Madeddu, G., Picarelli, C., De Marco, R., Cossu, M. V., Lagi, F., Cauda, R., De Luca, A., & Di Giambenedetto, S. (2017). Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients. AIDS, 31(3), 457-459. https://doi.org/10.1097/QAD.0000000000001357

@article{fc748b6a3f82454b860a3046059a773e,

title = "Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients",

abstract = "Not Available",

keywords = "Immunology, Immunology and Allergy, Infectious Diseases, Immunology, Immunology and Allergy, Infectious Diseases",

author = "Alberto Borghetti and Gianmaria Baldin and Amedeo Capetti and Gaetana Sterrantino and Stefano Rusconi and Alessandra Latini and Andrea Giacometti and Giordano Madeddu and Chiara Picarelli and \{De Marco\}, Ramona and Cossu, \{Maria V.\} and Filippo Lagi and Roberto Cauda and \{De Luca\}, Andrea and \{Di Giambenedetto\}, Simona",

year = "2017",

doi = "10.1097/QAD.0000000000001357",

language = "English",

volume = "31",

pages = "457--459",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

Borghetti, A, Baldin, G, Capetti, A, Sterrantino, G, Rusconi, S, Latini, A, Giacometti, A, Madeddu, G, Picarelli, C, De Marco, R, Cossu, MV, Lagi, F, Cauda, R, De Luca, A & Di Giambenedetto, S 2017, 'Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients', AIDS, vol. 31, no. 3, pp. 457-459. https://doi.org/10.1097/QAD.0000000000001357

TY - JOUR

T1 - Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients

AU - Borghetti, Alberto

AU - Baldin, Gianmaria

AU - Capetti, Amedeo

AU - Sterrantino, Gaetana

AU - Rusconi, Stefano

AU - Latini, Alessandra

AU - Giacometti, Andrea

AU - Madeddu, Giordano

AU - Picarelli, Chiara

AU - De Marco, Ramona

AU - Cossu, Maria V.

AU - Lagi, Filippo

AU - Cauda, Roberto

AU - De Luca, Andrea

AU - Di Giambenedetto, Simona

PY - 2017

Y1 - 2017

N2 - Not Available

AB - Not Available

KW - Immunology

KW - Immunology and Allergy

KW - Infectious Diseases

KW - Immunology

KW - Immunology and Allergy

KW - Infectious Diseases

UR - https://publicatt.unicatt.it/handle/10807/94825

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85010058269&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85010058269&origin=inward

U2 - 10.1097/QAD.0000000000001357

DO - 10.1097/QAD.0000000000001357

M3 - Article

SN - 0269-9370

VL - 31

SP - 457

EP - 459

JO - AIDS

JF - AIDS

IS - 3

ER -

Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Keywords

Access to Document

Other files and links

Fingerprint

Cite this